1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A	A	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	early	early	_	_	_	_	_	_	_
5	mRNA	mrna	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	G0/G1	g0/g1	_	_	_	_	_	_	_
9	switch	switch	_	_	_	_	_	_	_
10	gene	gene	_	_	_	_	_	_	_
11	2	2	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	G0S2	g0s2	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	cultured	culture	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	blood	blood	_	_	_	_	_	_	_
19	mononuclear	mononuclear	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A	A	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	CsA	CsA	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	achieve	achieve	_	_	_	_	_	_	_
8	its	its	_	_	_	_	_	_	_
9	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
10	effects	effect	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	inhibiting	inhibit	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	calcium-	calcium-	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	calmodulin-dependent	calmodulin-dependent	_	_	_	_	_	_	_
17	phosphatase	phosphatase	_	_	_	_	_	_	_
18	calcineurin	calcineurin	_	_	_	_	_	_	_
19	which	which	_	_	_	_	_	_	_
20	is	be	_	_	_	_	_	_	_
21	required	require	_	_	_	_	_	_	_
22	for	for	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	target	target	_	_	_	_	_	_	_
26	genes	gene	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	members	member	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	NFAT	NFAT	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	nuclear	nuclear	_	_	_	_	_	_	_
34	factor	factor	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	activated	activate	_	_	_	_	_	_	_
37	T	t	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	transcription	transcription	_	_	_	_	_	_	_
41	factor	factor	_	_	_	_	_	_	_
42	family	family	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Among	among	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	target	target	_	_	_	_	_	_	_
4	genes	gene	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	encoding	encode	_	_	_	_	_	_	_
9	interleukin-2	interleukin-2	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	IL2	IL2	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	cytokine	cytokine	_	_	_	_	_	_	_
16	facilitating	facilitate	_	_	_	_	_	_	_
17	progression	progression	_	_	_	_	_	_	_
18	through	through	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	G1	g1	_	_	_	_	_	_	_
21	phase	phase	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	cycle	cycle	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IL2	IL2	_	_	_	_	_	_	_
4	does	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	reverse	reverse	_	_	_	_	_	_	_
7	CsA	CsA	_	_	_	_	_	_	_
8	inhibition	inhibition	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	suggesting	suggest	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	at	at	_	_	_	_	_	_	_
13	least	least	_	_	_	_	_	_	_
14	one	one	_	_	_	_	_	_	_
15	other	other	_	_	_	_	_	_	_
16	NFAT-sensitive	nfat-sensitive	_	_	_	_	_	_	_
17	gene	gene	_	_	_	_	_	_	_
18	may	may	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	involved	involve	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	G0/G1	g0/g1	_	_	_	_	_	_	_
4	switch	switch	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	G0S2	G0S2	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	has	have	_	_	_	_	_	_	_
10	potential	potential	_	_	_	_	_	_	_
11	NFAT-binding	nfat-binding	_	_	_	_	_	_	_
12	sites	site	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	5	5	_	_	_	_	_	_	_
16	’	'	_	_	_	_	_	_	_
17	flank	flank	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	encodes	encode	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	small	small	_	_	_	_	_	_	_
22	basic	basic	_	_	_	_	_	_	_
23	potential	potential	_	_	_	_	_	_	_
24	phosphoprotein	phosphoprotein	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	unknown	unknown	_	_	_	_	_	_	_
27	function	function	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	sensitive	sensitive	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	reverse	reverse	_	_	_	_	_	_	_
6	transcription-polymerase	transcription-polymerase	_	_	_	_	_	_	_
7	chain	chain	_	_	_	_	_	_	_
8	reaction	reaction	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	RT-PCR	RT-PCR	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	assay	assay	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	G0S2	g0s2	_	_	_	_	_	_	_
15	mRNA	mrna	_	_	_	_	_	_	_
16	levels	level	_	_	_	_	_	_	_
17	were	be	_	_	_	_	_	_	_
18	assayed	assay	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	cultured	culture	_	_	_	_	_	_	_
21	blood	blood	_	_	_	_	_	_	_
22	mononuclear	mononuclear	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Freshly	freshly	_	_	_	_	_	_	_
2	isolated	isolate	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	contain	contain	_	_	_	_	_	_	_
5	high	high	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	G0S2	g0s2	_	_	_	_	_	_	_
9	mRNA	mRNA	_	_	_	_	_	_	_
10	which	which	_	_	_	_	_	_	_
11	rapidly	rapidly	_	_	_	_	_	_	_
12	decline	decline	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	“	``	_	_	_	_	_	_	_
3	spontaneous	spontaneous	_	_	_	_	_	_	_
4	stimulation	stimulation	_	_	_	_	_	_	_
5	”	''	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	noted	note	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	some	some	_	_	_	_	_	_	_
11	other	other	_	_	_	_	_	_	_
12	G0S	G0S	_	_	_	_	_	_	_
13	genes	gene	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	has	have	_	_	_	_	_	_	_
16	been	be	_	_	_	_	_	_	_
17	attributed	attribute	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	some	some	_	_	_	_	_	_	_
20	aspect	aspect	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	isolation	isolation	_	_	_	_	_	_	_
24	procedure	procedure	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	have	have	_	_	_	_	_	_	_
5	been	be	_	_	_	_	_	_	_
6	preincubated	preincubate	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	lower	lower	_	_	_	_	_	_	_
9	mRNA	mrna	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	there	there	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	transient	transient	_	_	_	_	_	_	_
16	increase	increase	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	G0S2	G0S2	_	_	_	_	_	_	_
19	mRNA	mRNA	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	peaking	peak	_	_	_	_	_	_	_
22	between	between	_	_	_	_	_	_	_
23	1-2	1-2	_	_	_	_	_	_	_
24	h	h	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	response	response	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	Concanavalin-A	Concanavalin-A	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	ConA	ConA	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	or	or	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	combination	combination	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	phorbol	phorbol	_	_	_	_	_	_	_
40	ester	ester	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	TPA	TPA	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	the	the	_	_	_	_	_	_	_
47	calcium	calcium	_	_	_	_	_	_	_
48	ionophore	ionophore	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	ionomycin	ionomycin	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	these	these	_	_	_	_	_	_	_
3	responses	response	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	CsA	CsA	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	G0S2	g0s2	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	required	require	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	commit	commit	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	enter	enter	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	G1	g1	_	_	_	_	_	_	_
16	phase	phase	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	cycle	cycle	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	that	that	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	while	while	_	_	_	_	_	_	_
26	not	not	_	_	_	_	_	_	_
27	excluding	exclude	_	_	_	_	_	_	_
28	other	other	_	_	_	_	_	_	_
29	possible	possible	_	_	_	_	_	_	_
30	targets	target	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	early	early	_	_	_	_	_	_	_
33	inhibition	inhibition	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	G0S2	g0s2	_	_	_	_	_	_	_
36	expression	expression	_	_	_	_	_	_	_
37	by	by	_	_	_	_	_	_	_
38	CsA	CsA	_	_	_	_	_	_	_
39	may	may	_	_	_	_	_	_	_
40	be	be	_	_	_	_	_	_	_
41	important	important	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	achieving	achieve	_	_	_	_	_	_	_
44	immunosuppression	immunosuppression	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	G0S2	G0S2	_	_	_	_	_	_	_
2	may	may	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	value	value	_	_	_	_	_	_	_
6	as	as	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	reporter	reporter	_	_	_	_	_	_	_
9	gene	gene	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	analyzing	analyze	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	mechanism	mechanism	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	action	action	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	CsA	CsA	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	its	its	_	_	_	_	_	_	_
20	influence	influence	_	_	_	_	_	_	_
21	on	on	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	positive	positive	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	negative	negative	_	_	_	_	_	_	_
26	selection	selection	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	lymphocytes	lymphocyte	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	response	response	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	self	self	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	not-self	not-self	_	_	_	_	_	_	_
35	antigens	antigen	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

